Check out these articles for some of the latest hot topics in ASC Industry News:
An old problem that’s still a big problem is back as the No. 1 issue on ECRI’s list of the top 10 patient safety concerns for 2020. Diagnostic errors—both missed and delayed diagnoses—topped the list. And a topic that’s been in the headlines this year—maternal health—was No. 2 on the list of patient safety hazards.
Source: Fierce Healthcare
Following a recent webinar presentation on “Days to Bill: Optimizing This Critical Key Performance Indicator,” Jho Outlaw, senior vice president of Revenue Cycle Services for SIS, and Jessica Nelson, director of Revenue Cycle Services for SIS, fielded questions from participants. Here are those questions, along with Outlaw’s and Nelson’s responses, summarized for readability.
Source: Surgical Information Systems
The Accreditation Association for Ambulatory Health Care (AAAHC) has released a new Pain Management Toolkit, offering providers guidance on acute and chronic pain treatment. As pain management has evolved over the last couple of decades, AAAHC has created this toolkit to provide information to health care providers serving the millions of U.S. adults facing chronic or acute pain.
Source: OR Today
Medical providers are being asked not to perform elective or non-essential surgery in an attempt to preserve resources for the coronavirus epidemic, according to new guidance from the Centers for Medicare & Medicaid Services (CMS). “The reality is clear, and the stakes are high: we need to preserve personal protective equipment for those on the front lines of this fight,” said CMS Administrator Seema Verma.
As the world continues its collective efforts at waging war against the rapidly spreading coronavirus, a handful of health tech devices and telemedicine tools are in the spotlight like never before. Many are being fast-tracked and called up to the front lines to treat the coronavirus pandemic. For example, MedWand can listen to your heart and lungs, measure respiratory rates and blood oxygen levels. Originally forecast to receive FDA approval in late summer, the device is now under consideration for emergency use authorization by the FDA.
Source: Multi-briefs: Exclusive